Novo Nordisk and AWS establish AI co‑innovation hub in London
- A London co‑innovation hub will combine AWS engineers and AI specialists with Novo Nordisk R&D to shorten the path from drug target to first human dose.
- AWS is Novo Nordisk’s preferred cloud provider and strategic AI partner to modernise infrastructure and scale life‑science workloads.
- The collaboration will use Amazon Bio Discovery, Amazon Bedrock and Bedrock AgentCore to identify targets, design therapies, connect genomic/imaging/clinical data and deploy AI agents.
- Novo Nordisk reports reduced clinical documentation time and productivity gains for more than 25,000 employees; the partnership builds on an existing relationship.
Partnership and purpose
Novo Nordisk and AWS have formed a strategic partnership to accelerate drug discovery and modernise operations through agentic AI and cloud technologies. They have created a co‑innovation hub in London where engineers and scientists from both organisations will use AWS AI tools with Novo Nordisk data and insights to compress the path from drug target to first human dose.
Technology and scope
Novo Nordisk has selected AWS as its preferred cloud provider and strategic AI partner. The collaboration will use services such as Amazon Bio Discovery and Amazon Bedrock to identify drug targets and design therapies faster, and will leverage Amazon Bedrock AgentCore to drive efficiencies across operations. AWS Forward Deployed Engineers are cited as part of the support to securely process complex datasets and scale findings across therapeutic areas.
Early results and scale
The companies say the work has already produced measurable results, including reductions in clinical documentation time and productivity improvements for more than 25,000 employees. The agreement is described as building secure foundations to turn early research breakthroughs into clinical trial design.
Commercial links
In addition to R&D collaboration, Novo Nordisk works with other Amazon businesses that support healthcare—Amazon Pharmacy, Amazon Ads and Amazon One Medical—to change how therapies are marketed and delivered.
Source: Novo Nordisk
